Hereditary Hemolytic

Overview of Hemolytic Anemias

  • Definition: Anemia caused by increased red blood cell (RBC) destruction (hemolysis), either intravascularly (within the blood vessels) or extravascularly (primarily in the spleen and liver)
  • Hallmarks:
    • Shortened RBC lifespan
    • Increased erythropoiesis (increased reticulocyte count)
    • Accumulation of hemoglobin breakdown products (e.g., bilirubin, LDH)
  • Classification:
    • Intrinsic (Inherited) Hemolytic Anemias:
      • Result from defects within the RBC itself
      • Include membrane defects, enzyme deficiencies, and hemoglobinopathies
    • Extrinsic (Acquired) Hemolytic Anemias:
      • Result from external factors that cause RBC destruction
      • Include immune-mediated hemolysis, mechanical trauma, infections, and chemical injury

Intrinsic Hemolytic Anemias: Membrane Defects

  • General Pathophysiology:

    • Defects in RBC membrane proteins disrupt the structural integrity and flexibility of the membrane
    • Abnormally shaped RBCs are more susceptible to splenic sequestration and destruction
  • Common Features:

    • Splenomegaly (due to increased splenic workload)
    • Jaundice (due to elevated bilirubin levels)
    • Increased osmotic fragility
  • Specific Membrane Defects:

    • Hereditary Spherocytosis (HS):
      • Defect: Primarily caused by mutations in genes encoding spectrin, ankyrin, band 3, or protein 4.2
        • These proteins are essential for maintaining the biconcave shape and flexibility of RBCs
      • Pathophysiology: Protein deficiencies lead to loss of membrane surface area, resulting in spherical-shaped RBCs (spherocytes)
        • Spherocytes have decreased deformability and are trapped and destroyed in the spleen
      • Clinical Findings:
        • Anemia (variable severity)
        • Jaundice
        • Splenomegaly
        • Bilirubin gallstones (cholelithiasis)
      • Laboratory Findings:
        • CBC:
          • Normal to decreased HGB and HCT
          • Normal or decreased MCV (may be falsely low due to spherocytes)
          • Increased MCHC (often >36 g/dL)
          • Increased RDW
        • Peripheral Blood Smear:
          • Spherocytes (hallmark finding)
          • Polychromasia (increased reticulocytes)
          • Absence of central pallor in spherocytes
        • Reticulocyte Count: Elevated
        • Direct Antiglobulin Test (DAT): Negative (unless there is a coexisting autoimmune process)
        • Osmotic Fragility Test: Increased osmotic fragility (RBCs lyse more readily in hypotonic solutions)
      • Treatment:
        • Splenectomy: Mainstay of treatment for severe HS
          • Reduces hemolysis and improves anemia
          • Increases risk of infection with encapsulated organisms (Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis)
          • Patients require vaccination before splenectomy
        • Folic acid supplementation
        • Blood transfusions (in severe cases)
    • Hereditary Elliptocytosis (HE):
      • Defect: Primarily caused by mutations in genes encoding spectrin, protein 4.1, or glycophorin C
      • Pathophysiology: Protein defects disrupt the horizontal interactions in the RBC cytoskeleton, leading to elliptical-shaped RBCs (elliptocytes)
      • Clinical Findings:
        • Most patients are asymptomatic
        • Variable degrees of anemia, splenomegaly, and jaundice
        • Severe forms (e.g., hereditary pyropoikilocytosis) can cause significant hemolysis
      • Laboratory Findings:
        • CBC:
          • Normal to decreased HGB and HCT
          • Normal MCV
          • Normal MCHC
        • Peripheral Blood Smear:
          • Elliptocytes (hallmark finding, >25% of RBCs)
          • Poikilocytosis (in severe forms)
        • Reticulocyte Count: Normal to slightly elevated
        • Osmotic Fragility Test: Usually normal
      • Treatment:
        • Most patients require no treatment
        • Splenectomy: May be considered in patients with severe hemolysis
        • Folic acid supplementation
        • Blood transfusions (in severe cases)
    • Hereditary Pyropoikilocytosis (HPP):
      • Defect: A severe form of hereditary elliptocytosis with compound heterozygosity for spectrin mutations
      • Pathophysiology: Marked spectrin deficiency leads to extreme poikilocytosis (abnormal RBC shapes) and heat sensitivity
        • RBCs fragment at temperatures that are normally well-tolerated
      • Clinical Findings:
        • Severe microcytic hemolytic anemia
        • Marked poikilocytosis
        • Splenomegaly
      • Laboratory Findings:
        • CBC:
          • Decreased HGB and HCT
          • Very low MCV
          • Increased RDW
        • Peripheral Blood Smear:
          • Extreme poikilocytosis (hallmark finding)
          • Microspherocytes, elliptocytes, fragmented cells
        • Reticulocyte Count: Elevated
      • Treatment:
        • Splenectomy: Mainstay of treatment
        • Folic acid supplementation
        • Blood transfusions (often required)
    • Hereditary Stomatocytosis:
      • Defect: Mutations affecting membrane cation permeability, particularly the PIEZO1 and stomatin (band 7) proteins
      • Pathophysiology: Altered cation permeability leads to changes in RBC volume and shape
        • Overhydrated Hereditary Stomatocytosis (OHS): Increased influx of sodium and water into RBCs, leading to swelling and stomatocytes (mouth-like appearance)
        • Dehydrated Hereditary Stomatocytosis (DHS): Increased efflux of potassium and water from RBCs, leading to dehydration and spiculated cells (e.g., echinocytes)
      • Clinical Findings:
        • Variable degrees of hemolytic anemia
        • Splenomegaly
        • Jaundice
      • Laboratory Findings:
        • CBC:
          • Variable HGB and HCT (depending on the severity of hemolysis)
          • Increased MCV (in OHS) or decreased MCV (in DHS)
        • Peripheral Blood Smear:
          • Stomatocytes (in OHS): RBCs with a slit-like area of central pallor
          • Spiculated cells (echinocytes) (in DHS)
        • Reticulocyte Count: Elevated
        • Osmotic Fragility Test: Variable (increased in OHS, decreased in DHS)
      • Treatment:
        • Splenectomy: May be considered in severe cases of OHS, but carries a risk of thrombosis
        • Iron overload: Can occur in DHS due to increased iron absorption
        • Folic acid supplementation
        • Blood transfusions (in severe cases)

Intrinsic Hemolytic Anemias: Enzyme Deficiencies

  • General Pathophysiology:

    • Deficiencies in enzymes essential for RBC metabolism disrupt energy production or antioxidant defenses
    • Leads to premature RBC destruction, especially under conditions of stress
  • Common Features:

    • Hemolytic anemia
    • Elevated reticulocyte count
    • Elevated indirect bilirubin
    • Decreased haptoglobin
  • Specific Enzyme Deficiencies:

    • Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency:
      • Defect: Deficiency of G6PD, an enzyme in the pentose phosphate pathway (hexose monophosphate shunt)
      • Pathophysiology:
        • G6PD is essential for producing NADPH, which protects RBCs from oxidative damage
        • Without NADPH, RBCs are vulnerable to oxidative stress from infections, drugs, or certain foods (e.g., fava beans)
        • Oxidative stress leads to hemoglobin denaturation and formation of Heinz bodies (denatured hemoglobin precipitates)
        • Heinz bodies damage the RBC membrane, leading to intravascular and extravascular hemolysis
      • Inheritance: X-linked recessive; more common in males
      • Clinical Findings:
        • Most individuals are asymptomatic until exposed to an oxidative stressor
        • Acute hemolytic anemia:
          • Sudden onset of jaundice, dark urine, and fatigue
          • Symptoms usually resolve within a few weeks after the oxidative stressor is removed
        • Chronic nonspherocytic hemolytic anemia (in some severe variants)
      • Laboratory Findings:
        • CBC:
          • Decreased HGB and HCT
        • Peripheral Blood Smear:
          • Bite cells (RBCs with a portion removed by splenic macrophages)
          • Heinz bodies (require special stain, e.g., crystal violet or brilliant green)
          • Polychromasia
        • Reticulocyte Count: Elevated
        • G6PD Assay:
          • Decreased G6PD enzyme activity (may be normal during acute hemolytic episodes due to increased reticulocytes)
      • Treatment:
        • Avoidance of oxidative stressors (certain drugs, foods, and infections)
        • Supportive care during hemolytic episodes:
          • Hydration
          • Blood transfusions (in severe cases)
        • Folic acid supplementation
    • Pyruvate Kinase (PK) Deficiency:
      • Defect: Deficiency of pyruvate kinase (PK), an enzyme in the glycolytic pathway (Embden-Meyerhof pathway)
      • Pathophysiology:
        • PK is essential for generating ATP, which is required to maintain RBC shape, membrane integrity, and ion transport
        • Without sufficient ATP, RBCs become rigid, dehydrated, and prone to splenic sequestration
        • Results in chronic hemolytic anemia
      • Inheritance: Autosomal recessive
      • Clinical Findings:
        • Chronic hemolytic anemia
        • Jaundice
        • Splenomegaly
        • Gallstones (cholelithiasis)
      • Laboratory Findings:
        • CBC:
          • Decreased HGB and HCT
          • Normal to decreased MCV (can be slightly macrocytic in some cases)
          • Normal MCHC
        • Peripheral Blood Smear:
          • Normal shape or slight poikilocytosis
          • No spherocytes
        • Reticulocyte Count: Markedly elevated
        • Pyruvate Kinase (PK) Assay:
          • Decreased PK enzyme activity
      • Treatment:
        • Blood transfusions (may be needed, especially in severe cases)
        • Splenectomy: May reduce transfusion requirements but increases the risk of thrombosis
        • Folic acid supplementation

General Laboratory Findings in Hemolytic Anemias

  • Increased Red Blood Cell Destruction:
    • Elevated indirect (unconjugated) bilirubin
    • Elevated lactate dehydrogenase (LDH)
    • Decreased haptoglobin (due to binding with free hemoglobin)
    • Hemoglobinuria (hemoglobin in the urine) in intravascular hemolysis
    • Hemosiderinuria (iron in the urine) in chronic intravascular hemolysis
  • Increased Red Blood Cell Production:
    • Elevated reticulocyte count
    • Polychromasia on peripheral blood smear

Key Terms

  • Hemolytic Anemia: Anemia caused by increased red blood cell destruction
  • Intrinsic Hemolytic Anemia: Hemolysis due to defects within the red blood cell
  • Extrinsic Hemolytic Anemia: Hemolysis due to external factors
  • Spherocytes: Spherical-shaped red blood cells (hallmark of hereditary spherocytosis)
  • Elliptocytes: Elliptical-shaped red blood cells (hallmark of hereditary elliptocytosis)
  • Stomatocytes: Red blood cells with a mouth-like appearance (seen in hereditary stomatocytosis)
  • Heinz Bodies: Denatured hemoglobin precipitates (seen in G6PD deficiency)
  • Osmotic Fragility: A measure of the resistance of red blood cells to lysis in hypotonic solutions
  • Reticulocyte: Immature red blood cell
  • Haptoglobin: Protein that binds free hemoglobin
  • Bilirubin: Product of heme breakdown
  • Enzyme Deficiency: Lack of a specific enzyme needed for proper red blood cell metabolism
  • Splenectomy: Surgical removal of the spleen